What is UroGen Pharma's retained earnings?

UroGen Pharma (URGN) reported retained earnings of -$983.29M in Q1 2026.

How has UroGen Pharma's retained earnings changed year-over-year?

UroGen Pharma's retained earnings decreased by 15.7% year-over-year, from -$850.07M to -$983.29M.

What is the long-term trend for UroGen Pharma's retained earnings?

Over 5 years (2020 to 2025), UroGen Pharma's retained earnings has grown at a 21.9% compound annual growth rate (CAGR), from -$356.5M to -$959.72M.

What does retained earnings mean?

Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.

UroGen Pharma URGN Retained Earnings

Retained Earnings at other companies

Bristol-Myers SquibbBMY

$18.29B+13.5%

PfizerPFE

$117.24B-2.0%

Johnson & JohnsonJNJ

$169.16B+4.0%

Merck & Co.MRK

$66.72B+0.9%

ImmunityBio, Inc.IBRX

-$4.36B-24.4%

Tyra Biosciences, Inc.TYRA

-$410.56M-46.9%

Other financials

Income statement

See full

Revenue$51.0M+152%

Gross profit$11.6M—

Operating income-$22.8M—

Net income-$23.6M+46.2%

EPS (diluted)-$1.17—

Balance sheet

See full

Cash & equivalents$110.0M+5.7%

Total debt$197.1M+56.0%

Total equity-$124.3M-167%

Total assets$253.7M+2.5%

Cash flow

See full

Operating cash flow-$45.3M-7.8%

CapEx$54.0K+22.7%

Free cash flow-$45.4M-7.8%

Valuation

See full

Market cap$1.73B+71.7%

Enterprise value$1.81B+80.9%

P/S12.3×+1.3×

Profitability

See full

Gross margin89.7%—

Operating margin-329.7%—

Net margin-94.8%-25.6pp

FCF margin-118.2%+1.3pp

Returns & leverage

See full

Return on equity-211.6%—

Debt / equity4.8×—

Current ratio4.7×-1.0×

Where this comes from

Reported directly by UroGen Pharma in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The official record: UroGen Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about UroGen Pharma's retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is UroGen Pharma's retained earnings?: UroGen Pharma (URGN) reported retained earnings of -$983.29M in Q1 2026.
How has UroGen Pharma's retained earnings changed year-over-year?: UroGen Pharma's retained earnings decreased by 15.7% year-over-year, from -$850.07M to -$983.29M.
What is the long-term trend for UroGen Pharma's retained earnings?: Over 5 years (2020 to 2025), UroGen Pharma's retained earnings has grown at a 21.9% compound annual growth rate (CAGR), from -$356.5M to -$959.72M.
What does retained earnings mean?: Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.